Phase Ib Study of Pembrolizumab in Combination With Chemo Radiotherapy (CRT) for Locally-advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Apr 2018.
- 06 Jun 2017 Safety results (n=27), presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 12 Jan 2017 Status changed from suspended to recruiting.